Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xihui Yin

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Distinct Type 1 Immune Networks Underlie the Severity of Restrictive Lung Disease after COVID-19Glenda Canderan, Lyndsey M Muehling, Alexandra Kadl, et al.
Nature Immunology|March 27, 2025
Distinct type 1 immune networks underlie the severity of restrictive lung disease after COVID-19Glenda Canderan, Lyndsey M Muehling, Alexandra Kadl, et al.
The Journal of Clinical Investigation|December 16, 2025
UTX coordinates TCF1 and STAT3 to control progenitor CD8+ T cell fate in autoimmune diabetesHo-Chung Chen, Madison F Bang, Hsing-Hui Wang, et al.
Research Square|January 25, 2022
Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infectionsAllan Feng, Emily Yang, Andrew Moore, et al.
JCI Insight|February 8, 2023
Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illnessAllan Feng, Emily Y Yang, Andrew Reese Moore, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Distinct Type 1 Immune Networks Underlie the Severity of Restrictive Lung Disease after COVID-19Glenda Canderan, Lyndsey M Muehling, Alexandra Kadl, et al.
Nature Immunology|March 27, 2025
Distinct type 1 immune networks underlie the severity of restrictive lung disease after COVID-19Glenda Canderan, Lyndsey M Muehling, Alexandra Kadl, et al.
The Journal of Clinical Investigation|December 16, 2025
UTX coordinates TCF1 and STAT3 to control progenitor CD8+ T cell fate in autoimmune diabetesHo-Chung Chen, Madison F Bang, Hsing-Hui Wang, et al.
Research Square|January 25, 2022
Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infectionsAllan Feng, Emily Yang, Andrew Moore, et al.
JCI Insight|February 8, 2023
Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illnessAllan Feng, Emily Y Yang, Andrew Reese Moore, et al.
Pageof 2